Group A Streptococcal M1 Protein Sequesters Cathelicidin to Evade Innate Immune Killing.

Christopher N LaRock, Simon D��hrmann, Jordan Todd, Ross Corriden, Joshua Olson, Timo Johannssen, Bernd Lepenies, Richard L Gallo, Partho Ghosh, Victor Nizet
Author Information
  1. Christopher N LaRock: Department of Pediatrics, University of California, San Diego, La Jolla, CA 92093, USA.
  2. Simon D��hrmann: Department of Pediatrics, University of California, San Diego, La Jolla, CA 92093, USA.
  3. Jordan Todd: Department of Pediatrics, University of California, San Diego, La Jolla, CA 92093, USA.
  4. Ross Corriden: Department of Pediatrics, University of California, San Diego, La Jolla, CA 92093, USA.
  5. Joshua Olson: Department of Pediatrics, University of California, San Diego, La Jolla, CA 92093, USA.
  6. Timo Johannssen: Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14476 Potsdam, Germany; Institute of Chemistry and Biochemistry, Department of Biology, Chemistry and Pharmacy, Freie Universit��t Berlin, 14195 Berlin, Germany.
  7. Bernd Lepenies: Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14476 Potsdam, Germany; Institute of Chemistry and Biochemistry, Department of Biology, Chemistry and Pharmacy, Freie Universit��t Berlin, 14195 Berlin, Germany; Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, 30559 Hannover, Germany.
  8. Richard L Gallo: Department of Pediatrics, University of California, San Diego, La Jolla, CA 92093, USA; Department of Dermatology, University of California, San Diego, La Jolla, CA 92093, USA.
  9. Partho Ghosh: Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA 92093, USA.
  10. Victor Nizet: Department of Pediatrics, University of California, San Diego, La Jolla, CA 92093, USA; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093, USA. Electronic address: vnizet@ucsd.edu.

Abstract

The antimicrobial peptide LL-37 is generated upon proteolytic cleavage of cathelicidin and limits invading pathogens by directly targeting microbial membranes as well as stimulating innate immune cell function. However, some microbes evade LL-37-mediated defense. Notably, group A Streptococcus (GAS) strains belonging to the hypervirulent M1T1 serogroup are more resistant to human LL-37 than other GAS serogroups. We show that the GAS surface-associated M1 protein sequesters and neutralizes LL-37 antimicrobial activity through its N-terminal domain. M1 protein also binds the cathelicidin precursor hCAP-18, preventing its proteolytic maturation into antimicrobial forms. Exogenous M1 protein rescues M1-deficient GAS from killing by neutrophils and within neutrophil extracellular traps and neutralizes LL-37 chemotactic properties. M1 also binds murine cathelicidin, and its virulence contribution in a murine model of necrotizing skin infection is largely driven by its ability to neutralize this host defense peptide. Thus, cathelicidin resistance is essential for the pathogenesis of hyperinvasive M1T1 GAS.

References

  1. Science. 2008 Mar 7;319(5868):1405-8 [PMID: 18323455]
  2. Biochim Biophys Acta. 2015 Nov;1848(11 Pt B):3047-54 [PMID: 25701232]
  3. Emerg Infect Dis. 2008 Oct;14(10):1511-7 [PMID: 18826812]
  4. Trends Immunol. 2009 Mar;30(3):131-41 [PMID: 19217824]
  5. J Innate Immun. 2009;1(3):202-14 [PMID: 20375578]
  6. Eur J Immunol. 2010 Apr;40(4):1118-26 [PMID: 20140902]
  7. J Innate Immun. 2010;2(6):534-45 [PMID: 20798480]
  8. Nature. 2011 Apr 7;472(7341):64-8 [PMID: 21475196]
  9. Br J Dermatol. 2012 May;166(5):1023-34 [PMID: 22136668]
  10. J Immunol. 2012 Jul 1;189(1):304-11 [PMID: 22634613]
  11. Clin Microbiol Infect. 2013 May;19(5):E222-9 [PMID: 23464795]
  12. J Immunol. 2008 Jun 1;180(11):7565-73 [PMID: 18490758]
  13. J Exp Med. 2000 Oct 2;192(7):1069-74 [PMID: 11015447]
  14. Blood. 2001 Jun 15;97(12):3951-9 [PMID: 11389039]
  15. J Invest Dermatol. 2001 Jul;117(1):91-7 [PMID: 11442754]
  16. Nature. 2001 Nov 22;414(6862):454-7 [PMID: 11719807]
  17. Lancet. 2002 Oct 12;360(9340):1144-9 [PMID: 12387964]
  18. J Invest Dermatol. 2003 May;120(5):810-6 [PMID: 12713586]
  19. J Immunol. 2004 Mar 1;172(5):3070-7 [PMID: 14978112]
  20. Proc Natl Acad Sci U S A. 1981 Aug;78(8):4689-93 [PMID: 7029524]
  21. Cell. 1997 Feb 21;88(4):553-60 [PMID: 9038346]
  22. J Biol Chem. 1999 Aug 6;274(32):22445-51 [PMID: 10428818]
  23. Lancet Infect Dis. 2005 Nov;5(11):685-94 [PMID: 16253886]
  24. Science. 2006 Mar 24;311(5768):1770-3 [PMID: 16497887]
  25. Nat Med. 2006 Jun;12(6):636-41 [PMID: 16751768]
  26. FASEB J. 2006 Oct;20(12):2068-80 [PMID: 17012259]
  27. Infect Immun. 2006 Dec;74(12):6982-91 [PMID: 17030578]
  28. J Bacteriol. 2007 Mar;189(5):1514-22 [PMID: 17142387]
  29. Nat Med. 2007 Aug;13(8):975-80 [PMID: 17676051]
  30. Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4498-508 [PMID: 17898271]
  31. Curr Protein Pept Sci. 2013 Sep;14(6):504-14 [PMID: 23968350]
  32. Clin Microbiol Rev. 2014 Apr;27(2):264-301 [PMID: 24696436]
  33. Lab Invest. 2014 Sep;94(9):991-1002 [PMID: 24955895]
  34. Biochem J. 2014 Nov 15;464(1):3-11 [PMID: 25181554]

Grants

  1. AI077780/NIAID NIH HHS
  2. R01 AI096837/NIAID NIH HHS
  3. R01 AI052453/NIAID NIH HHS
  4. AI052453/NIAID NIH HHS
  5. R37 AI052453/NIAID NIH HHS
  6. R56 AI096837/NIAID NIH HHS
  7. R01 AI077780/NIAID NIH HHS
  8. AI096837/NIAID NIH HHS

MeSH Term

Animals
Antigens, Bacterial
Antimicrobial Cationic Peptides
Bacterial Outer Membrane Proteins
Carrier Proteins
Disease Models, Animal
Humans
Immune Evasion
Mice
Protein Binding
Skin Diseases, Bacterial
Streptococcal Infections
Streptococcus pyogenes
Cathelicidins

Chemicals

Antigens, Bacterial
Antimicrobial Cationic Peptides
Bacterial Outer Membrane Proteins
Carrier Proteins
streptococcal M protein
Cathelicidins

Word Cloud

Created with Highcharts 10.0.0GASM1LL-37cathelicidinantimicrobialproteinpeptideproteolyticdefenseM1T1neutralizesalsobindsmurinegenerateduponcleavagelimitsinvadingpathogensdirectlytargetingmicrobialmembraneswellstimulatinginnateimmunecellfunctionHowevermicrobesevadeLL-37-mediatedNotablygroupStreptococcusstrainsbelonginghypervirulentserogroupresistanthumanserogroupsshowsurface-associatedsequestersactivityN-terminaldomainprecursorhCAP-18preventingmaturationformsExogenousrescuesM1-deficientkillingneutrophilswithinneutrophilextracellulartrapschemotacticpropertiesvirulencecontributionmodelnecrotizingskininfectionlargelydrivenabilityneutralizehostThusresistanceessentialpathogenesishyperinvasiveGroupStreptococcalProteinSequestersCathelicidinEvadeInnateImmuneKilling

Similar Articles

Cited By